EFDID: 26764EFD: View Filing

Issuer: Genesis Biopharma, Inc (0001425205) - D

Accession: 0001483806-10-000007 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001425205
  • Entity Name:
    Genesis Biopharma, Inc
  • Entity Type:
    Corporation
  • Jurisdiction:
    NEVADA
  • Year of Inc:
    Within 5 years (2007)
  • Address:
    1601 N. SEPULVEDA BLVD., #632
    MANHATTAN BEACH, CA 90266
  • Persons:
    Related Persons 5
    Robert T. Brooke
    Executive OfficerDirector
    RICHARD MCKILLIGAN
    Executive OfficerDirector
    MARK J. AHN
    Director
    IBRAHIM ABOTALEB
    Promoter
    GERALD LEWIS
    Promoter
EDGAR: Offering Information
  • Accession Date:
    11/05/2010
  • First Sale Date:
    10/22/2010
  • Offering Amount:
    $250,000
  • Amount Sold:
    $250,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Genesis Biopharma, Inc/s/ Robert T. BrookeRobert T. BrookeChief Executive Officer2010-11-05